Andrea Sutton
Adult Health · Birmingham, ALNPI 1467725267
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,499 of the $20,758 with a category attached, or 65.0%. Biohaven Pharmaceuticals, Inc. accounts for 77.8% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2021 at $20,205 and has fallen 99.9% since, to $24 in 2024. Among adult health clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 324 payments — averaging $64.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$16K
- AbbVie$695
- CSL Behring$641
- Amgen$446
- UCB, Inc.$353
- Novartis$301
- plus $2K from 26 others
What the payments were for
- Speaking & faculty fees$13,49965%
- Travel & lodging$1,4807%
- Food & beverage$5,77128%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 74 | $16,155 |
| AbbVie(2 entities) | 54 | $695 |
| CSL Behring | 14 | $641 |
| Amgen | 26 | $446 |
| UCB, Inc. | 21 | $353 |
| Novartis | 17 | $301 |
| Biogen | 14 | $280 |
| Acorda Therapeutics, Inc | 17 | $254 |
| Lundbeck LLC | 9 | $196 |
| Adamas Pharmaceuticals, Inc. | 8 | $172 |
| Acadia Pharmaceuticals Inc | 9 | $155 |
| Kyowa Kirin, Inc. | 8 | $151 |
| Sunovion Pharmaceuticals Inc. | 11 | $149 |
| Teva Pharmaceuticals USA, Inc. | 8 | $129 |
| SK Life Science, Inc. | 4 | $106 |
| EMD Serono, Inc. | 4 | $88 |
| Avanir Pharmaceuticals, Inc. | 4 | $79 |
| Eisai Inc. | 3 | $62 |
| Johnson & Johnson | 2 | $49 |
| Supernus Pharmaceuticals, Inc. | 3 | $47 |
| Lilly USA, LLC | 3 | $37 |
| Upsher-smith Laboratories LLC | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| AstraZeneca | 1 | $19 |
| Biodelivery Sciences International, Inc. | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Sanofi | 1 | $17 |
| Tanabe Pharma America, Inc. | 1 | $16 |
| Merck | 1 | $14 |
| Neurelis, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$15,167
- Hizentra$125
How this compares
$20,758 in reported general payments places this provider in the 95th percentile of 308 adult health providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other adult health in Birmingham
- Lanier OhareBirmingham$42K
- Jessica WrightBirmingham$33K
- Sara HopperBirmingham$21K
- Laura RomundstadBirmingham$10K
- Jane DavisBirmingham$9K
- Anissa ThomasBirmingham$8K
- Chelsey KahlerBirmingham$5K
- Mary WadeBirmingham$5K
- Merry WoodsBirmingham$4K
- Taneaka Rowe-HouserBirmingham$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.